ARCHIVES

NTP Board Oks Seven Compounds For Tests

This article is from The Cancer Letter archive.

Vol. 09 No. 16 | April 22, 1983

Download PDF Visit The Full Archive

Related Articles

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990

In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease

February 20, 1998

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013